Therapeutics

Andrey Tolkachev Oncology drug developer (Intensity Therapeutics)Nasdaq: INTS) increased its proposed initial public offering to $15 million from $8 million. The biotech company said in an filing that it is now considering offering 3.25…

Five things you need to know before the market opens on Tuesday, May 16:1. - Stock futures drop as focus on debt ceiling talksUS stock futures fell on Tuesday, while the dollar gave up gains against its global peers and Treasury yields…

Mirati Therapeutics (MRTX) announces the publication of updated clinical data for adagrasib Merati Therapeutics (NASDAQ:), Inc.® (MRTX) today Journal of Clinical Oncology Posted in speed contact data suggest Increase the…